Sort
85,873 grants matching “alzheimers”
Alzheimer's Disease Research Center
$2,509,367John Morris · Washington University · P50 · FY2006 · AG
Health and Financial Implications of Early-Stage Alzheimer's Disease and Related Dementias
$2,508,769Lauren Hersch Nicholas · University Of Colorado Denver · RF1 · FY2020 · AG
In vivo modelling and therapy development for stathmin-2 loss in TDP-43 proteinopathies
$2,507,311Clotilde Lagier-Tourenne · Massachusetts General Hospital · RF1 · FY2021 · NS
Causes and Consequences of Healthcare Efficiency
$2,507,115Jonathan S Skinner · Dartmouth College · P01 · FY2018 · AG
Translating Dosage Compensation to Trisomy
$2,507,052Jeanne Bentley Lawrence · Univ Of Massachusetts Med Sch Worcester · RC4 · FY2010 · GM
Catecholaminergic Signaling in Normal Cognition, Aging and Models of Alzheimer's Disease
$2,506,077Steven A Thomas · University Of Pennsylvania · RF1 · FY2020 · AG
Proteostasis in Aging and Neurodegenerative Disease
$2,505,973Richard I. Morimoto · Northwestern University · P01 · FY2020 · AG
Multigenerational Longitudinal Panel for Research on Aging
$2,505,657Steven Ruggles · University Of Minnesota · R01 · FY2025 · AG
Phase 1 Clinical Trial of CMS121, a Novel Therapeutic Candidate for Alzheimer's Disease
$2,503,169William C Raschke · Virogenics, Inc. · R01 · FY2021 · AG
Multimodal imaging of prodromal synaptic, circuit, and network-level dysfunction in a murine model of Alzheimer's disease
$2,503,003Takuya Toyonaga · Yale University · RF1 · FY2022 · NS
Alzheimer's Disease Research Center at Columbia University
$2,501,608Michael Shelanski · Columbia University Health Sciences · P50 · FY2011 · AG
Genotyping the Understanding America Study to generate novel opportunities for research on cognitive functioning and dementia
$2,501,339Titus Johannes Galama · University Of Southern California · R01 · FY2025 · AG
Alzheimer's Disease Neuroimaging Initiative
$2,500,790Michael W Weiner · Northern California Institute/Res/Edu · U01 · FY2015 · AG
Alzheimer's Disease Neuroimaging Initiative
$2,500,000Michael W Weiner · Northern California Institute/Res/Edu · U01 · FY2009 · AG
Center for Sub-Cellular Genomics
$2,500,000Junhyong Kim · University Of Pennsylvania · RM1 · FY2022 · HG
Open-label extension of a 3-month blinded clinical trial of PTI-125
$2,499,896Lindsay H Burns · Cassava Sciences, Inc · R44 · FY2020 · AG
Modulation Of Neuronal Channels and Receptors in the Brain
$2,499,546Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES
The Role of Chemical Exposures in Alzheimer's Disease (AD) and its Trajectory
$2,499,382Rima F Kaddurah-Daouk · Duke University · U01 · FY2024 · AG
Apolipoprotein E genotype modulates brain mitovesicle production, a component of mitochondrial quality control
$2,499,343Efrat Levy · Nathan S. Kline Institute For Psych Res · RF1 · FY2024 · AG
Alzheimer's Disease Research Center
$2,499,318John Morris · Washington University · P50 · FY2007 · AG
Impact of Medicare Polices on Beneficiaries with ADRD
$2,497,615John Hsu · Massachusetts General Hospital · RF1 · FY2023 · AG
Quantitative real-time characterization of single-cell aging: from phenotypes to
$2,497,500Murat Acar · Yale University · DP2 · FY2014 · AG
Perimenopause in Brain Aging and Alzheimer's Disease
$2,496,919Roberta Diaz Brinton · University Of Arizona · P01 · FY2020 · AG
Proteopathies of the Aging Central Nervous
$2,495,388J. David Gladstone Institutes · P01 · FY2005 · AG
Neuroinflammatory mechanisms of aging-related vascular cognitive impairment (VCI)
$2,495,260Nabil J. Alkayed · Oregon Health & Science University · RF1 · FY2017 · AG